These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 11343038

  • 21. Efficacy and acceptability of a new topical skin lotion of sodium cromoglicate (Altoderm) in atopic dermatitis in children aged 2-12 years: a double-blind, randomized, placebo-controlled trial.
    Stainer R, Matthews S, Arshad SH, McDonald S, Robinson J, Schapira C, Foote KD, Baird-Snell M, Gregory T, Pollock I, Stevens MT, Edwards AM.
    Br J Dermatol; 2005 Feb; 152(2):334-41. PubMed ID: 15727648
    [Abstract] [Full Text] [Related]

  • 22. Children with autistic spectrum disorders. II: parents are unable to distinguish secretin from placebo under double-blind conditions.
    Coplan J, Souders MC, Mulberg AE, Belchic JK, Wray J, Jawad AF, Gallagher PR, Mitchell R, Gerdes M, Levy SE.
    Arch Dis Child; 2003 Aug; 88(8):737-9. PubMed ID: 12876178
    [Abstract] [Full Text] [Related]

  • 23. Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study.
    Biederman J, Swanson JM, Wigal SB, Kratochvil CJ, Boellner SW, Earl CQ, Jiang J, Greenhill L.
    Pediatrics; 2005 Dec; 116(6):e777-84. PubMed ID: 16322134
    [Abstract] [Full Text] [Related]

  • 24. Naltrexone in autistic children: a double-blind and placebo-controlled study.
    Campbell M, Anderson LT, Small AM, Locascio JJ, Lynch NS, Choroco MC.
    Psychopharmacol Bull; 1990 Dec; 26(1):130-5. PubMed ID: 2196621
    [Abstract] [Full Text] [Related]

  • 25. Multiple doses of secretin in the treatment of autism: a controlled study.
    Sponheim E, Oftedal G, Helverschou SB.
    Acta Paediatr; 2002 Dec; 91(5):540-5. PubMed ID: 12113323
    [Abstract] [Full Text] [Related]

  • 26. Secretin and autism: a two-part clinical investigation.
    Chez MG, Buchanan CP, Bagan BT, Hammer MS, McCarthy KS, Ovrutskaya I, Nowinski CV, Cohen ZS.
    J Autism Dev Disord; 2000 Apr; 30(2):87-94. PubMed ID: 10832772
    [Abstract] [Full Text] [Related]

  • 27. Efficacy and tolerability of oxymorphone immediate release for acute postoperative pain after abdominal surgery: a randomized, double-blind, active- and placebo-controlled, parallel-group trial.
    Aqua K, Gimbel JS, Singla N, Ma T, Ahdieh H, Kerwin R.
    Clin Ther; 2007 Jun; 29(6):1000-12. PubMed ID: 17692717
    [Abstract] [Full Text] [Related]

  • 28. Efficacy of porcine secretin in children with autism and pervasive developmental disorder.
    Kern JK, Van Miller S, Evans PA, Trivedi MH.
    J Autism Dev Disord; 2002 Jun; 32(3):153-60. PubMed ID: 12108616
    [Abstract] [Full Text] [Related]

  • 29. A controlled trial of a training course for parents of children with suspected autism spectrum disorder.
    McConachie H, Randle V, Hammal D, Le Couteur A.
    J Pediatr; 2005 Sep; 147(3):335-40. PubMed ID: 16182672
    [Abstract] [Full Text] [Related]

  • 30. Levetiracetam versus placebo in childhood and adolescent autism: a double-blind placebo-controlled study.
    Wasserman S, Iyengar R, Chaplin WF, Watner D, Waldoks SE, Anagnostou E, Soorya L, Hollander E.
    Int Clin Psychopharmacol; 2006 Nov; 21(6):363-7. PubMed ID: 17012983
    [Abstract] [Full Text] [Related]

  • 31. A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder.
    Biederman J, Melmed RD, Patel A, McBurnett K, Konow J, Lyne A, Scherer N, SPD503 Study Group.
    Pediatrics; 2008 Jan; 121(1):e73-84. PubMed ID: 18166547
    [Abstract] [Full Text] [Related]

  • 32. Tianeptine: a novel strategy of psychopharmacological treatment of children with autistic disorder.
    Niederhofer H, Staffen W, Mair A.
    Hum Psychopharmacol; 2003 Jul; 18(5):389-93. PubMed ID: 12858327
    [Abstract] [Full Text] [Related]

  • 33. Intravenous human recombinant tumor necrosis factor receptor p55-Fc IgG1 fusion protein Ro 45-2081 (lenercept): a double blind, placebo controlled dose-finding study in rheumatoid arthritis.
    Rau R, Sander O, van Riel P, van de Putte L, Hasler F, Zaug M, Kneer J, van der Auwera P, Stevens RM, Rheumatology Group 791.
    J Rheumatol; 2003 Apr; 30(4):680-90. PubMed ID: 12672184
    [Abstract] [Full Text] [Related]

  • 34. Testosterone therapy in men with Parkinson disease: results of the TEST-PD Study.
    Okun MS, Fernandez HH, Rodriguez RL, Romrell J, Suelter M, Munson S, Louis ED, Mulligan T, Foster PS, Shenal BV, Armaghani SJ, Jacobson C, Wu S, Crucian G.
    Arch Neurol; 2006 May; 63(5):729-35. PubMed ID: 16682542
    [Abstract] [Full Text] [Related]

  • 35. Role of risperidone in children with autism spectrum disorder.
    Chavez B, Chavez-Brown M, Rey JA.
    Ann Pharmacother; 2006 May; 40(5):909-16. PubMed ID: 16684811
    [Abstract] [Full Text] [Related]

  • 36. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
    Dodick DW, Mauskop A, Elkind AH, DeGryse R, Brin MF, Silberstein SD, BOTOX CDH Study Group.
    Headache; 2005 Apr; 45(4):315-24. PubMed ID: 15836567
    [Abstract] [Full Text] [Related]

  • 37. Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/hyperactivity disorder in school-aged children and adolescents: A 4-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled, forced-dose-escalation study.
    Spencer TJ, Abikoff HB, Connor DF, Biederman J, Pliszka SR, Boellner S, Read SC, Pratt R.
    Clin Ther; 2006 Mar; 28(3):402-18. PubMed ID: 16750455
    [Abstract] [Full Text] [Related]

  • 38. [Comparison of attachment-related social behaviors in autistic disorder and developmental disability].
    Akdemir D, Pehlivantürk B, Unal F, Ozusta S.
    Turk Psikiyatri Derg; 2009 Mar; 20(2):105-17. PubMed ID: 19504361
    [Abstract] [Full Text] [Related]

  • 39. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K, Kato Y, Kohno H, Takano K, Tanaka T, Teramoto A, Shimatsu A.
    Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
    [Abstract] [Full Text] [Related]

  • 40. A controlled, randomized, double-blind trial to evaluate the effect of a supplement of cocoa husk that is rich in dietary fiber on colonic transit in constipated pediatric patients.
    Castillejo G, Bulló M, Anguera A, Escribano J, Salas-Salvadó J.
    Pediatrics; 2006 Sep; 118(3):e641-8. PubMed ID: 16950955
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.